🔗 Permalink

Inventor profile of:

Everett Hurteau Meyer

City:

Belmont, California

Country:

United States

Published Applications:

Last publication date:

2024-10-17

Top Assignees for applications by Everett Hurteau Meyer

The entities that hold a legal rights for patent applications filed by inventor Meyer Everett Hurteau:

The Board of Trustees of the Leland Stanford Junior University 3 Stanford, CA United States
The Board of Trustees of the Leland Stanford Junior University 1 Stanford, CT United States

Recent patent applications by Meyer Everett Hurteau

Everett Hurteau Meyer from Belmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-17

US20240344027A1

Chemistry; metallurgy

METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

#2 | 2024-01-25

US20240024362A1

Human necessities

DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE

#3 | 2023-11-23

US20230372393A1

Human necessities

METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

#4 | 2022-12-01

US20220380729A1

Chemistry; metallurgy

METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

#5 | 2022-08-25

US20220267428A1

Chemistry; metallurgy

BLOCKADE OF RGMb FOR TREATING INFLAMMATORY BOWEL DISEASE AND COLITIS

#6 | 2021-02-04

US20210030797A1

Human necessities

Methods for allogenic hematopoietic stem cell transplantation

#7 | 2021-01-21

US20210015862A1

Human necessities

Methods for allogenic hematopoietic stem cell transplantation

#8 | 2021-01-07

US20210002613A1

Chemistry; metallurgy

METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

#9 | 2019-10-10

US20190307795A1

Human necessities

REGULATORY T CELLS TARGETED WITH CHIMERIC ANTIGEN RECEPTORS

#10 | 2019-10-03

US20190298774A1

Human necessities

Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases

#11 | 2019-03-14

US20190077861A1

Chemistry; metallurgy

Blockade of RGMB for reducing transplantation-associated inflammation leading to loss of function of a transplanted organ in a graft recipient

InventorID:

2452487 ⎘